Trial Profile
SOMATULINE Autogel 90 mg IN DUMPING SYNDROME
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Jan 2023
Price :
$35
*
At a glance
- Drugs Lanreotide (Primary)
- Indications Dumping syndrome
- Focus Therapeutic Use
- 24 Oct 2018 Primary endpoint has been met as per the results presented at the 26th United European Gastroenterology Week.
- 24 Oct 2018 Results presented at the 26th United European Gastroenterology Week
- 24 Oct 2018 Status changed from recruiting to completed.